Preeti Dusaj, MD
Psychiatry · Springfield, MONPI 1295046506
Payments from drug & device makers
Across 118 payments — averaging $13.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$667
- Neurocrine Biosciences, Inc.$232
- Sunovion Pharmaceuticals Inc.$188
- Otsuka America Pharmaceutical, Inc.$135
- Johnson & Johnson$82
- Vanda Pharmaceuticals Inc.$76
- plus $252 from 6 others
What the payments were for
- Food & beverage$1,632100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $667 |
| Neurocrine Biosciences, Inc. | 12 | $232 |
| Sunovion Pharmaceuticals Inc. | 13 | $188 |
| Otsuka America Pharmaceutical, Inc. | 8 | $135 |
| Johnson & Johnson | 5 | $82 |
| Vanda Pharmaceuticals Inc. | 5 | $76 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| Ironshore Pharmaceuticals Inc. | 3 | $51 |
| Lundbeck LLC | 2 | $29 |
| Neuronetics, Inc. | 2 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$1,632 in reported general payments places this provider in the 70th percentile of 680 psychiatry providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 15 | $1,664 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 30 | $1,294 |
| Hydroxyzine Hcl | 37 | $1,209 |
| Aripiprazole | 27 | $1,180 |
| Divalproex Sodium | 26 | $864 |
| Lamotrigine | 50 | $684 |
| Trazodone Hcl | 86 | $668 |
| Quetiapine Fumarate | 42 | $651 |
| Sertraline Hcl | 36 | $605 |
| Clonazepam | 56 | $474 |
| Duloxetine Hcl | 27 | $389 |
| Prazosin Hcl | 18 | $231 |
| Gabapentin | 24 | $229 |
| Buspirone Hcl | 32 | $213 |
| Benztropine Mesylate | 21 | $212 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Springfield
- Alok JainSpringfield$64K
- Lorri DarrowSpringfield$47K
- Gregory MattingleySaint Charles$8.2M
- Junaid SyedSaint Louis$8M
- Eric CarbonellFestus$5.4M
- Ricky MofsenSaint Louis$4.9M
- Charles ConwaySaint Louis$3.8M
- Mohd MalikSaint Louis$2.8M
- Franco SicuroOlivette$2.3M
- Howard IlivickySaint Charles$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.